Niagen Bioscience (NAGE) Assets (2011 - 2026)

Niagen Bioscience (NAGE) has reported Assets for 14 consecutive years, with $114.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Assets rose 40.56% year-over-year to $114.3 million; the TTM figure through Mar 2026 stood at $114.3 million (up 40.56% YoY), while the FY2025 annual figure was $106.4 million, up 55.84% from the prior year.
• Assets improved to $114.3 million in Q1 2026 per NAGE's latest filing, from $106.4 million in the prior quarter.
• Across five years, Assets topped out at $114.3 million in Q1 2026 and bottomed at $45.7 million in Q3 2022.
• Historically, Assets has averaged $67.0 million across 5 years, with a median of $54.1 million in 2024.
• Annual changes were most pronounced in 2022 — Assets dropped 29.2% — and 2025, when it surged 73.63%.
• Niagen Bioscience's Assets stood at $54.1 million in 2022, then grew by 1.68% to $55.0 million in 2023, then advanced by 24.22% to $68.3 million in 2024, then jumped by 55.84% to $106.4 million in 2025, then rose by 7.45% to $114.3 million in 2026.
• Business Quant data shows NAGE's Assets at $114.3 million in Q1 2026, $106.4 million in Q4 2025, and $98.1 million in Q3 2025.